Steven Cohen Cyma Bay Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.63 - $24.47 $1.82 Million - $3.52 Million	143,776 Added 5.92%	2,573,700 $60.8 Million
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $26.4 Million - $42.8 Million	2,429,924 New	2,429,924 $36.2 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $121,110 - $197,525	20,597 New	20,597 $179,000
Q2 2022 Aug 15, 2022	BUY	$1.72 - $3.39 $602,000 - $1.19 Million	350,000 New	350,000 $1.03 Million
Q1 2022 May 16, 2022	SELL	$2.77 - $3.64 $1.89 Million - $2.48 Million	-681,401 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.23 - $4.6 $2.2 Million - $3.13 Million	681,401 New	681,401 $2.3 Million
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $1.91 Million - $4.17 Million	-576,638 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $813,059 - $2.45 Million	576,638 New	576,638 $2.01 Million
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $4.2 Million - $18.7 Million	-3,160,600 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$5.12 - $7.21 $3.78 Million - $5.32 Million	-738,030 Reduced 18.93%	3,160,600 $16.2 Million
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $23.6 Million - $53.3 Million	3,898,630 New	3,898,630 $27.9 Million
Q1 2019 May 15, 2019	SELL	$8.16 - $13.42 $1.79 Million - $2.95 Million	-219,715 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.54 - $11.74 $951,687 - $1.71 Million	145,518 Added 196.12%	219,715 $1.73 Million
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.52 $807,263 - $1.08 Million	74,197 New	74,197 $822,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.